PRPO

Precipio, Inc. is a leading oncology diagnostics and reagent technology company headquartered in New Haven, Connecticut, dedicated to revolutionizing cancer diagnosis and enhancing patient outcomes. The company leverages cutting-edge technologies to deliver a comprehensive suite of diagnostic products and services tailored for healthcare providers in the U.S. oncology market. With a strong commitment to precision medicine, Precipio stands at the forefront of improving treatment selection and monitoring, positioning itself as an essential contributor to advancement in cancer care.